Medical School · Year 2 · Endocrine · includes a quiz and discussion video

Lecture 1: Hypothalamus and Pituitary Anatomy and Physiology

Unit 2.3: Endocrine System

Learning Objectives

By the end of this lecture, students will be able to:

1. Describe the anatomy of the hypothalamus and pituitary gland
2. Explain the hypothalamic-pituitary axis and feedback mechanisms
3. Describe the hypothalamic releasing and inhibiting hormones
4. Explain anterior pituitary hormone synthesis and function
5. Describe posterior pituitary hormone synthesis and release
6. Explain the blood supply and clinical correlations

Lecture Outline

I. Hypothalamic Anatomy

The hypothalamus serves as the master integration center connecting the nervous system to the endocrine system, coordinating autonomic function, endocrine regulation, and behavioral responses into unified physiological responses. Despite weighing only approximately four grams, this region of the ventral diencephalon exerts profound influence over homeostatic processes throughout the body.

Location and boundaries define the hypothalamus as forming the floor and lateral walls of the third ventricle. The optic chiasm marks its anterior boundary, while the mammillary bodies define the posterior extent. Superiorly, the hypothalamus transitions into the thalamus, and inferiorly it connects to the pituitary gland via the infundibulum (pituitary stalk). This strategic location allows integration of visual, limbic, and brainstem inputs with hormonal output.

The hypothalamic nuclei form organized clusters of neurons with specialized functions. The paraventricular nucleus (PVN) produces corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), and the posterior pituitary hormones oxytocin and antidiuretic hormone (ADH). The supraoptic nucleus (SON) primarily synthesizes ADH and oxytocin, with its large magnocellular neurons projecting directly to the posterior pituitary. The arcuate nucleus produces gonadotropin-releasing hormone (GnRH), growth hormone-releasing hormone (GHRH), and dopamine (which inhibits prolactin). The ventromedial nucleus functions as the satiety center, while the lateral hypothalamus serves as the hunger center—lesions of these areas cause obesity and starvation, respectively. The suprachiasmatic nucleus receives direct retinal input and serves as the master circadian pacemaker. The preoptic area regulates body temperature, with distinct warm-sensitive and cold-sensitive neuronal populations.

Connections of the hypothalamus include afferent inputs from the limbic system (amygdala, hippocampus), brainstem nuclei (particularly regarding autonomic control), cerebral cortex, and retina. Efferent projections travel to the pituitary gland (both through the portal system and neuronal axons), autonomic nuclei in the brainstem and spinal cord, and limbic structures. The hypothalamic-pituitary connection occurs through two distinct pathways: the portal vascular system delivers releasing hormones to the anterior pituitary, while direct axonal projections carry oxytocin and ADH to the posterior pituitary.

<image>Panel A: Midsagittal brain section showing hypothalamus position ventral to the thalamus, with optic chiasm anteriorly, mammillary bodies posteriorly, and pituitary stalk descending inferiorly. Panel B: Enlarged coronal view of the hypothalamus with color-coded nuclei including paraventricular, supraoptic, arcuate, ventromedial, lateral hypothalamic area, suprachiasmatic, and preoptic nuclei. Panel C: Afferent input pathways from limbic system, brainstem, and retina converging on hypothalamic nuclei. Panel D: Efferent output pathways from hypothalamus to pituitary gland, brainstem autonomic centers, and limbic structures.</image>

II. Pituitary Anatomy

The pituitary gland (hypophysis) resides in the sella turcica, a bony depression in the sphenoid bone resembling a Turkish saddle, protected on all sides by bone except superiorly where it communicates with the brain. This small but critical gland, weighing only 0.5-1 gram and measuring approximately 1 cm in diameter, produces hormones controlling thyroid function, adrenal function, reproduction, growth, and lactation.

The pituitary consists of two embryologically and functionally distinct parts. The anterior pituitary (adenohypophysis) comprises approximately 80% of the gland and develops from Rathke's pouch, an invagination of oral ectoderm that migrates upward during development. This epithelial origin explains why anterior pituitary tumors (adenomas) are common—epithelial cells retain proliferative capacity. The anterior pituitary contains five distinct hormone-producing cell types. The posterior pituitary (neurohypophysis) develops from the diencephalon as a downward extension of neural tissue, explaining why it contains axon terminals rather than secretory cells—hormones are synthesized in hypothalamic nuclei and merely stored and released from the posterior pituitary.

Relations of the pituitary have profound clinical significance. The optic chiasm lies immediately superior to the pituitary, separated only by a thin layer of dura—expansion of pituitary tumors compresses the chiasm, characteristically causing bitemporal hemianopia (loss of temporal visual fields bilaterally) because fibers from the nasal retina, which cross in the chiasm, carry temporal visual field information. The cavernous sinuses lie lateral to the pituitary, containing cranial nerves III, IV, V1, V2, and VI, as well as the internal carotid artery—lateral tumor extension can cause cranial nerve palsies. The sphenoid sinus lies inferior, providing the surgical corridor for transsphenoidal pituitary surgery, which approaches the gland through the nose and sphenoid sinus without traversing brain tissue.

The blood supply differs between anterior and posterior components. The anterior pituitary receives no direct arterial supply; instead, the superior hypophyseal arteries (from the internal carotid) form a primary capillary plexus in the median eminence, where hypothalamic releasing hormones are secreted into the blood. Portal veins then carry this blood down the pituitary stalk to a secondary capillary plexus in the anterior pituitary, delivering concentrated releasing hormones directly to their target cells. The posterior pituitary receives direct arterial supply from the inferior hypophyseal arteries.

<image>Panel A: Midsagittal view of pituitary in the sella turcica showing anatomical relations with optic chiasm superiorly, cavernous sinus laterally, and sphenoid sinus inferiorly. Panel B: Cross-sectional view distinguishing anterior pituitary (adenohypophysis) from posterior pituitary (neurohypophysis) with infundibular connection. Panel C: Embryological development diagram showing Rathke's pouch migration from oral ectoderm and infundibulum descent from neural ectoderm. Panel D: Pie chart of anterior pituitary cell type distribution showing somatotrophs 50%, lactotrophs 15-25%, corticotrophs 15-20%, gonadotrophs 10-15%, and thyrotrophs 5%.</image>

III. Hypothalamic-Pituitary Portal System

The hypothalamic-pituitary portal system represents a specialized vascular arrangement that delivers hypothalamic hormones directly to the anterior pituitary at high concentrations, enabling minute quantities of releasing hormones to effectively control pituitary secretion.

The anatomy of this portal system begins with the superior hypophyseal arteries, branches of the internal carotid artery that supply the median eminence and upper infundibulum. These arteries form the primary capillary plexus, fenestrated capillaries in the median eminence where hypothalamic neurons release their hormones. This region lies outside the blood-brain barrier, allowing direct secretion into the bloodstream. From the primary plexus, long portal veins descend along the pituitary stalk, carrying hormone-laden blood to the secondary capillary plexus within the anterior pituitary. Here, releasing hormones diffuse out to reach their target cells. This arrangement constitutes a portal system because blood passes through two capillary beds in sequence (similar to the hepatic portal system).

The functional significance of this arrangement is profound. Hypothalamic hormones reach the anterior pituitary at concentrations 10-100 times higher than if they were diluted in the systemic circulation. This allows the hypothalamus to control pituitary function with minimal hormone production. The close proximity also enables rapid feedback: pituitary hormones can diffuse back to affect hypothalamic neurons, creating short-loop feedback.

Clinical correlations emphasize the vulnerability of this system. Pituitary stalk transection (from trauma or surgery) interrupts portal flow, causing anterior pituitary hormone deficiency with one notable exception—prolactin levels rise rather than fall. This occurs because prolactin is the only anterior pituitary hormone under tonic inhibition (by dopamine); removing dopamine inhibition by cutting the stalk allows prolactin to rise unopposed. This phenomenon helps distinguish stalk lesions from primary pituitary failure. Pituitary apoplexy (hemorrhage or infarction into a pituitary adenoma) can destroy the portal system, causing acute panhypopituitarism. Sheehan syndrome (postpartum pituitary necrosis) results from hypotension during delivery causing infarction of the enlarged, hyperemic pituitary of pregnancy.

<image>Panel A: Coronal section through median eminence showing hypothalamic neurons projecting to the primary capillary plexus with superior hypophyseal artery supply. Panel B: Long portal veins descending along pituitary stalk to secondary capillary plexus surrounding anterior pituitary cells, with inferior hypophyseal artery supplying posterior pituitary. Panel C: Schematic diagram illustrating the two-capillary-bed concept that defines a portal system with hormone concentration gradients. Panel D: Clinical correlations including stalk transection causing hyperprolactinemia, pituitary apoplexy with hemorrhage into adenoma, and Sheehan syndrome showing postpartum pituitary necrosis.</image>

IV. Hypothalamic Releasing and Inhibiting Hormones

Hypothalamic neurons produce small peptide hormones that travel through the portal system to regulate anterior pituitary hormone secretion. These releasing and inhibiting hormones provide the critical link between neural inputs and endocrine outputs.

Releasing hormones stimulate anterior pituitary hormone secretion. Corticotropin-releasing hormone (CRH), a 41-amino acid peptide from the paraventricular nucleus, stimulates corticotrophs to release ACTH. CRH secretion follows a circadian rhythm (highest in the morning) and increases dramatically with stress. Thyrotropin-releasing hormone (TRH), a tripeptide (pyroglutamyl-histidyl-proline-amide), stimulates thyrotrophs to release TSH and also stimulates prolactin release—this explains why severe primary hypothyroidism (with markedly elevated TRH) can cause hyperprolactinemia. Gonadotropin-releasing hormone (GnRH), a decapeptide from the arcuate nucleus, stimulates gonadotrophs to release both FSH and LH. Critically, GnRH must be released in a pulsatile fashion (approximately every 60-90 minutes) for normal gonadotropin secretion; continuous GnRH administration paradoxically suppresses FSH and LH through receptor downregulation—a principle exploited therapeutically with GnRH agonists in prostate cancer and endometriosis. Growth hormone-releasing hormone (GHRH), a 44-amino acid peptide, stimulates somatotrophs to release growth hormone.

Inhibiting hormones suppress anterior pituitary secretion. Dopamine, released from arcuate nucleus neurons, provides tonic inhibition of prolactin release from lactotrophs. Unlike all other anterior pituitary hormones, prolactin is under constant inhibition—removing this inhibition (by dopamine antagonists, pituitary stalk section, or hypothalamic lesions) causes hyperprolactinemia. Somatostatin (growth hormone-inhibiting hormone/GHIH), a 14-amino acid peptide, inhibits growth hormone release and also inhibits TSH. Somatostatin analogs (octreotide, lanreotide) exploit this inhibitory action in treating acromegaly and neuroendocrine tumors.

The pulsatile nature of hypothalamic hormone release has important physiological implications. GnRH pulsatility determines gonadotropin secretion patterns—different pulse frequencies favor FSH versus LH release. GHRH pulses, occurring predominantly during sleep, explain the nocturnal surges of growth hormone. CRH follows circadian rhythm, with hypothalamic-pituitary-adrenal axis activity peaking in the early morning, preparing the body for daily activities.

<image>Panel A: Hypothalamic nuclei diagram showing paraventricular nucleus producing CRH and TRH, and arcuate nucleus producing GnRH, GHRH, and dopamine, with arrows descending through the portal system. Panel B: Anterior pituitary cell types arranged showing corticotrophs, thyrotrophs, gonadotrophs, somatotrophs, and lactotrophs with their respective stimulatory and inhibitory inputs. Panel C: Dopamine tonic inhibition of lactotrophs highlighted, demonstrating that prolactin is uniquely under constant inhibitory control. Panel D: Pulsatile release patterns showing GnRH pulses every 60-90 minutes, CRH circadian rhythm with morning peak, and GHRH nocturnal surges during sleep.</image>

V. Anterior Pituitary Hormones

The anterior pituitary contains five distinct hormone-producing cell types, each responding to specific hypothalamic signals and releasing hormones that control peripheral endocrine glands or exert direct effects on target tissues. The classic mnemonic FLAT PIG helps recall these hormones: FSH, LH, ACTH, TSH, Prolactin, (Ignore), GH.

Somatotrophs constitute approximately 50% of anterior pituitary cells and produce growth hormone (GH), also called somatotropin. GH is a 191-amino acid protein released in pulsatile fashion, with the largest pulses occurring during slow-wave sleep. Release is stimulated by GHRH, ghrelin, sleep, exercise, hypoglycemia, and amino acids; release is inhibited by somatostatin, IGF-1, and hyperglycemia. GH has both direct metabolic effects (promoting lipolysis, antagonizing insulin, stimulating gluconeogenesis) and indirect growth effects mediated through insulin-like growth factor-1 (IGF-1), produced primarily in the liver. IGF-1 mediates most of GH's growth-promoting actions and participates in negative feedback to the pituitary and hypothalamus.

Lactotrophs comprise 15-25% of anterior pituitary cells and produce prolactin, a 199-amino acid protein essential for lactation. Uniquely among anterior pituitary hormones, prolactin is under tonic inhibition by dopamine; removing this inhibition (stalk section, dopamine antagonists) causes hyperprolactinemia. TRH also stimulates prolactin release. Prolactin's primary function is promoting breast milk production; it also inhibits GnRH pulsatility, explaining lactational amenorrhea. Prolactin levels rise dramatically during pregnancy, reaching 10-20 times normal at term.

Corticotrophs make up 15-20% of anterior pituitary cells and produce adrenocorticotropic hormone (ACTH), which stimulates the adrenal cortex to synthesize cortisol. ACTH is cleaved from a larger precursor, pro-opiomelanocortin (POMC), which also yields melanocyte-stimulating hormone (MSH) and β-endorphin. CRH stimulates ACTH release, while cortisol provides negative feedback. The ACTH-MSH relationship explains hyperpigmentation in ACTH excess states: when ACTH is markedly elevated (Addison's disease, Nelson syndrome), excess MSH causes darkening of skin, especially in sun-exposed areas, pressure points, and mucous membranes.

<image>Panel A: Anterior pituitary cell type distribution showing somatotrophs 50%, lactotrophs 15-25%, corticotrophs 15-20%, gonadotrophs 10-15%, and thyrotrophs 5% as colored sectors. Panel B: Somatotroph regulation and function showing GHRH and ghrelin stimulation, somatostatin inhibition, GH release to liver for IGF-1 production, and nocturnal pulsatile secretion pattern. Panel C: Lactotroph regulation showing unique dopamine tonic inhibition, TRH stimulation, prolactin release for lactation, and GnRH suppression causing lactational amenorrhea. Panel D: Corticotroph regulation showing POMC cleavage to ACTH, MSH, and beta-endorphin, CRH stimulation, cortisol feedback, and hyperpigmentation mechanism in ACTH excess states.</image>

VI. Anterior Pituitary Hormones (continued)

Thyrotrophs, the least numerous anterior pituitary cell type at approximately 5%, produce thyroid-stimulating hormone (TSH), also called thyrotropin. TSH is a glycoprotein hormone consisting of an alpha subunit (common to TSH, FSH, LH, and hCG) and a unique beta subunit that confers biological specificity. TRH from the hypothalamus stimulates TSH release, while thyroid hormones (primarily T3) provide negative feedback at both pituitary and hypothalamic levels. TSH binds to the TSH receptor on thyroid follicular cells, stimulating all aspects of thyroid hormone synthesis and secretion. The TSH receptor is a G protein-coupled receptor signaling primarily through cAMP; autoantibodies against this receptor cause Graves' disease (stimulating antibodies) or occasionally hypothyroidism (blocking antibodies).

Gonadotrophs represent 10-15% of anterior pituitary cells and uniquely produce two hormones: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Both are glycoproteins sharing the same alpha subunit as TSH and hCG, with distinct beta subunits. GnRH stimulates release of both hormones, though the ratio varies with GnRH pulse frequency—faster pulses favor LH, slower pulses favor FSH. In males, FSH acts on Sertoli cells in the seminiferous tubules to support spermatogenesis, while LH acts on Leydig cells in the interstitium to stimulate testosterone synthesis. In females, FSH acts on granulosa cells to promote follicular development and estrogen synthesis, while LH triggers ovulation at mid-cycle and supports corpus luteum function. Sex steroids (testosterone, estrogen) and inhibin (from Sertoli cells or granulosa cells) provide negative feedback, with one important exception: in females at mid-cycle, rising estrogen levels trigger a positive feedback response, causing the LH surge that induces ovulation.

The glycoprotein hormone family (TSH, FSH, LH, and placental hCG) shares structural similarities that have clinical implications. All contain the identical alpha subunit; beta subunits differ and determine receptor specificity. The beta subunits of LH and hCG are nearly identical, explaining why hCG can bind LH receptors—this allows hCG to maintain the corpus luteum in early pregnancy. Some pituitary adenomas and germ cell tumors secrete only alpha subunit, detectable as elevated free alpha subunit levels. In thyrotrophic adenomas, the disproportionate secretion of alpha subunit relative to complete TSH provides a diagnostic clue.

<image>Panel A: Glycoprotein hormone structure showing common alpha subunit with distinct beta subunits for TSH, FSH, LH, and hCG, noting beta similarity between LH and hCG. Panel B: Male gonadotropin actions showing FSH acting on Sertoli cells for spermatogenesis and LH acting on Leydig cells for testosterone production, with feedback pathways. Panel C: Female menstrual cycle hormone graph showing FSH and LH patterns, with mid-cycle estrogen positive feedback triggering the LH surge for ovulation. Panel D: TSH receptor signaling on thyroid follicular cells showing Gs-cAMP pathway activation and sites where Graves disease stimulating antibodies bind.</image>

VII. Posterior Pituitary Hormones

Unlike the anterior pituitary, which synthesizes its own hormones, the posterior pituitary serves as a storage and release site for hormones synthesized in hypothalamic neurons. The axons of these neurons form the hypothalamo-hypophyseal tract, extending from the hypothalamus through the pituitary stalk to terminate in the posterior pituitary.

The synthesis and transport pathway begins in the paraventricular (PVN) and supraoptic (SON) nuclei of the hypothalamus, where magnocellular neurons synthesize oxytocin and antidiuretic hormone (ADH/vasopressin). These hormones are synthesized as prohormones, packaged into vesicles along with carrier proteins called neurophysins (neurophysin I for oxytocin, neurophysin II for ADH), and transported down the axons by fast axoplasmic transport. The journey from cell body to posterior pituitary takes 12-24 hours. Hormones are stored in the axon terminals in the posterior pituitary, released in response to action potentials that propagate down the axons. This neurosecretory arrangement allows rapid, neurally-controlled hormone release.

Antidiuretic hormone (ADH), also called arginine vasopressin (AVP), is a nine-amino acid peptide primarily regulating water balance. The principal stimulus for ADH release is increased plasma osmolality, detected by osmoreceptors in the hypothalamus—a rise of just 1-2% above the set point (approximately 280-290 mOsm/kg) triggers ADH release. Decreased blood volume (>10% reduction) and decreased blood pressure also stimulate ADH release through baroreceptors, though these volume/pressure stimuli are less sensitive than osmotic stimuli. Other stimuli include nausea (a potent releaser), pain, and various medications. ADH acts primarily through V2 receptors in the renal collecting duct, activating adenylyl cyclase and causing insertion of aquaporin-2 water channels into the apical membrane. This allows water reabsorption from the collecting duct, concentrating the urine and retaining body water. V1a receptors on vascular smooth muscle cause vasoconstriction, contributing to blood pressure maintenance.

Oxytocin, structurally similar to ADH (differing by only two amino acids), has distinct functions centered on reproduction and social bonding. Suckling is the primary physiological stimulus, with sensory afferents from the nipple triggering oxytocin release that causes contraction of myoepithelial cells surrounding breast alveoli, ejecting milk (the "let-down" reflex). Cervical dilation during labor triggers the Ferguson reflex, a positive feedback loop where oxytocin release causes uterine contractions, which cause further cervical dilation, triggering more oxytocin release until delivery occurs. This is one of the few physiological examples of positive feedback. Oxytocin also contributes to postpartum uterine involution, reducing hemorrhage.

<image>Panel A: Hypothalamo-hypophyseal tract showing magnocellular neurons in PVN and SON, axons descending through pituitary stalk with hormone-neurophysin vesicles, and terminal boutons in posterior pituitary adjacent to fenestrated capillaries. Panel B: ADH physiology showing osmoreceptor and baroreceptor inputs, V2 receptor activation in collecting duct with aquaporin-2 insertion, and V1a receptor vasoconstriction effects. Panel C: Oxytocin physiology illustrating the suckling reflex pathway for milk ejection and the Ferguson reflex positive feedback loop for uterine contractions during labor. Panel D: Molecular structures of ADH and oxytocin peptides side by side, highlighting the two amino acid differences that confer distinct receptor specificities.</image>

VIII. Feedback Mechanisms

The endocrine system maintains homeostasis through elaborate feedback mechanisms that ensure appropriate hormone levels for physiological needs. Understanding these feedback loops is essential for interpreting hormone levels and diagnosing endocrine disorders.

Negative feedback is the predominant regulatory mechanism, where end-organ hormones inhibit their own production pathway. Long-loop feedback occurs when target organ hormones (cortisol, thyroid hormones, sex steroids) inhibit both hypothalamic releasing hormone secretion and pituitary hormone release. This is the primary feedback mechanism for the HPA, HPT, and HPG axes. Short-loop feedback involves pituitary hormones feeding back to inhibit hypothalamic releasing hormones—for example, ACTH can directly inhibit CRH release. Ultra-short loop feedback occurs when hypothalamic hormones inhibit their own release from the same neurons.

The hypothalamic-pituitary-adrenal (HPA) axis exemplifies these feedback principles. CRH from the hypothalamus stimulates ACTH release from pituitary corticotrophs. ACTH stimulates the adrenal cortex to produce cortisol, which then inhibits both CRH and ACTH release. The HPA axis also demonstrates circadian regulation, with CRH and ACTH release peaking in the early morning hours, resulting in cortisol levels highest upon awakening (preparing the body for daily activities) and lowest at midnight. Stress overrides circadian rhythm, with physical or psychological stressors triggering CRH release regardless of time of day.

The hypothalamic-pituitary-thyroid (HPT) axis operates similarly. TRH stimulates TSH release, TSH stimulates thyroid hormone production, and T3 (the active hormone, converted from T4 by pituitary type 2 deiodinase) inhibits both TRH and TSH secretion. The relationship between T4 and TSH is log-linear, meaning that small changes in T4 produce large changes in TSH. This exquisite sensitivity makes TSH the most sensitive indicator of thyroid dysfunction—even subtle thyroid hormone excess or deficiency produces measurable TSH changes before T4 levels become overtly abnormal.

The hypothalamic-pituitary-gonadal (HPG) axis adds complexity with both negative and positive feedback. GnRH pulses stimulate FSH and LH release. Sex steroids (testosterone in males; estrogen and progesterone in females) provide negative feedback. Additionally, inhibin from the gonads (Sertoli cells in males, granulosa cells in females) specifically inhibits FSH without affecting LH. The unique feature of the female HPG axis is the positive feedback response at mid-cycle: as follicular estrogen rises above a threshold and remains elevated for approximately 36 hours, it triggers an LH surge rather than suppressing it. This positive feedback is essential for ovulation and does not occur in males.

<image>Panel A: Diagram of feedback loop types showing long-loop feedback from target organ hormones, short-loop feedback from pituitary hormones, and ultra-short loop feedback within hypothalamic neurons. Panel B: HPA axis diagram showing CRH-ACTH-cortisol cascade with cortisol negative feedback to hypothalamus and pituitary, plus circadian rhythm graph with morning cortisol peak. Panel C: HPT axis diagram showing TRH-TSH-T4/T3 cascade with log-linear TSH-T4 relationship demonstrating that small T4 changes cause large TSH changes. Panel D: HPG axis diagram showing GnRH-FSH/LH-sex steroids cascade with negative feedback, inhibin selective FSH inhibition, and female mid-cycle positive feedback triggering the LH surge.</image>

IX. Development and Embryology

Understanding pituitary development explains the distinct embryological origins of the anterior and posterior pituitary, provides insight into congenital abnormalities, and accounts for the cell types found in each division.

Anterior pituitary development begins during the fourth week of embryonic development when Rathke's pouch, an ectodermal invagination from the roof of the primitive oral cavity (stomodeum), extends upward toward the developing brain. By the eighth week, Rathke's pouch separates from the oral cavity and differentiates into the anterior pituitary components: the pars distalis (the main anterior lobe), pars tuberalis (wrapping around the infundibulum), and pars intermedia (between anterior and posterior lobes, vestigial in humans). The connection to the oral cavity normally disappears, but remnants can persist and give rise to craniopharyngiomas, benign tumors that often present in childhood with visual disturbances, growth failure, and hypopituitarism. The epithelial origin of the anterior pituitary from Rathke's pouch explains why adenomas (epithelial tumors) are common while neural tumors are not.

Posterior pituitary development occurs simultaneously but from a different source. During the fourth week, the infundibulum develops as a downward extension of the diencephalon (neural ectoderm). This neural tissue becomes the posterior pituitary (neurohypophysis), the infundibulum (pituitary stalk), and the median eminence. The neural origin explains why the posterior pituitary contains axon terminals rather than secretory cells—it is essentially brain tissue.

Transcription factors determine anterior pituitary cell fate in a hierarchical cascade. Pit-1 (also called POU1F1) is essential for differentiation of somatotrophs, lactotrophs, and thyrotrophs—mutations cause combined pituitary hormone deficiency affecting GH, prolactin, and TSH. PROP1 acts upstream of Pit-1 and is required for Pit-1 expression plus additional effects on gonadotrophs—PROP1 mutations cause the most common genetic form of combined pituitary hormone deficiency, affecting GH, prolactin, TSH, and often FSH/LH. T-PIT (also called TBX19) is specifically required for corticotroph differentiation—mutations cause isolated ACTH deficiency. SF-1 is necessary for gonadotroph development. These transcription factor pathways explain why certain combinations of hormone deficiencies occur together in genetic pituitary disorders.

<image>Panel A: Week 4-8 developmental timeline showing Rathke's pouch invaginating from stomodeum and infundibulum descending from diencephalon, with progressive separation and differentiation. Panel B: Formation of anterior pituitary components (pars distalis, tuberalis, intermedia) from Rathke's pouch and posterior pituitary from infundibulum, with craniopharyngioma arising from pouch remnants. Panel C: Transcription factor cascade showing PROP1 leading to Pit-1 for somatotroph, lactotroph, and thyrotroph differentiation, with T-PIT for corticotrophs and SF-1 for gonadotrophs. Panel D: Table of genetic mutation phenotypes showing Pit-1 mutation causing GH/prolactin/TSH deficiency, PROP1 mutation causing combined deficiency, and T-PIT mutation causing isolated ACTH deficiency.</image>

X. Clinical Correlations

Several clinically important conditions affect the hypothalamus and pituitary, presenting with hormone excess, hormone deficiency, or mass effects from structural lesions.

Pituitary adenomas are the most common pituitary pathology, found incidentally in 10-15% of autopsies and 10% of brain MRIs. Classification includes size (microadenoma <10 mm, macroadenoma ≥10 mm, giant adenoma ≥40 mm) and function (functioning adenomas secrete excess hormone; non-functioning cause only mass effects). Functional adenomas include prolactinomas (most common), GH-secreting adenomas (causing acromegaly), ACTH-secreting adenomas (causing Cushing disease), and rare TSH-secreting or gonadotropin-secreting tumors. Mass effects depend on size and direction of growth: superior extension compresses the optic chiasm causing bitemporal hemianopia; lateral extension into the cavernous sinus causes cranial nerve palsies; compression of normal pituitary tissue causes hypopituitarism.

Hypopituitarism refers to deficiency of one or more pituitary hormones. Causes include pituitary tumors (most common), surgical or radiation damage, vascular events (Sheehan syndrome, apoplexy), inflammatory conditions (lymphocytic hypophysitis, sarcoidosis, hemochromatosis), infiltrative diseases, trauma, and genetic conditions. The typical order of hormone loss with progressive pituitary damage is GH first (most sensitive), followed by FSH/LH, then TSH, then ACTH (most resistant, and most critical)—though this order varies. ACTH deficiency is life-threatening and must be identified and treated; TSH deficiency causes hypothyroidism but is not immediately dangerous. Importantly, when replacing hormones, cortisol must be replaced before thyroid hormone because levothyroxine increases cortisol metabolism and can precipitate adrenal crisis in a patient with undiagnosed ACTH deficiency.

Empty sella syndrome occurs when the sella turcica appears empty on imaging because CSF fills the space, flattening the pituitary against the sellar floor. Primary empty sella results from a defect in the diaphragma sellae allowing CSF to herniate into the sella; it is often discovered incidentally and may not affect pituitary function. Secondary empty sella follows surgery, radiation, or infarction. Despite the dramatic radiological appearance, many patients retain normal pituitary function.

Pituitary apoplexy is a clinical emergency involving hemorrhage or infarction within a pituitary adenoma. Patients present acutely with severe headache, visual loss, ophthalmoplegia, and altered consciousness. Acute adrenal insufficiency may occur if corticotroph function is lost. Treatment includes immediate glucocorticoid administration and consideration of urgent surgical decompression if visual impairment is present.

<image>Panel A: Pituitary adenoma size classification showing microadenoma less than 10mm, macroadenoma 10mm or greater, and giant adenoma 40mm or greater, with mass effect diagram showing optic chiasm compression and cavernous sinus extension. Panel B: Hypopituitarism causes including tumor compression, Sheehan syndrome, radiation, and trauma, with hormone loss order diagram showing GH most sensitive and ACTH most resistant. Panel C: Empty sella syndrome MRI appearance showing CSF filling the sella with flattened pituitary, comparing primary diaphragma defect versus secondary post-surgical causes. Panel D: Pituitary apoplexy showing hemorrhage into adenoma with acute presentation of headache, vision loss, and altered consciousness, emphasizing immediate corticosteroid administration.</image>

Summary

The hypothalamus serves as the integration center linking the nervous system to the endocrine system, with specific nuclei producing releasing and inhibiting hormones that control anterior pituitary function, plus oxytocin and ADH that are stored in the posterior pituitary.

The hypothalamic-pituitary portal system delivers releasing hormones directly to the anterior pituitary at high concentrations, enabling minute quantities of hypothalamic hormones to effectively control pituitary secretion. Interruption of this system (stalk section) causes panhypopituitarism with the exception of hyperprolactinemia (loss of dopamine inhibition).

The anterior pituitary contains five cell types producing six hormones: somatotrophs (GH), lactotrophs (prolactin), corticotrophs (ACTH), thyrotrophs (TSH), and gonadotrophs (FSH and LH). Each is regulated by hypothalamic hormones and provides feedback to the hypothalamus and pituitary.

The posterior pituitary stores and releases ADH (regulating water balance through V2 receptors in the collecting duct) and oxytocin (promoting milk ejection and uterine contraction).

Feedback mechanisms maintain hormonal homeostasis, with long-loop negative feedback from target organ hormones being the predominant mechanism. The female HPG axis uniquely demonstrates mid-cycle positive feedback, enabling ovulation.

Pituitary pathology includes functioning and non-functioning adenomas, hypopituitarism from various causes, empty sella syndrome, and pituitary apoplexy. When treating hypopituitarism, cortisol must be replaced before thyroid hormone to avoid precipitating adrenal crisis.

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown